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Abstract 
Objective: Periodic structured violence risk assessment is the principle method underlying 
treatment planning for mentally disordered offenders but little is known about how risk 
changes over time. We aimed to determine whether hospitalised patients underwent reliable 
clinical change in assessed risk.  
Method: We used a pseudo-prospective longitudinal study design. Demographic, clinical and 
risk assessment data of adult inpatients (N=480) who had been routinely assessed with the 
HCR-20 on two to four occasions over a mean period of 17 months (SD=2) were collated. 
Linear mixed models regression was conducted to determine change over time on total, 
subscale, and individual item scores, and relative change between clinical and demographic 
groups. The Reliable Change Index was calculated to examine whether change was greater 
than that expected by measurement error; clinically significant change was defined as the 
extent to which HCR-20 scores reduced below previously reported scores for patients not 
requiring hospitalisation.    
Results: HCR-20 total score (Estimate -0.42, 95% CI=-0.84, -0.01, p<.05; d=.20) and clinical 
score (Estimate=-0.42, 95% CI=-0.64, -0.20, p<.001; d=.36) reduced over assessments. 
Significant differences in change were evident between clinically and demographically 
defined groups.  A maximum of 3% of individuals showed clinically significant reliable 
reductions in HCR-20 total scores. The scores of patients whose overall level of risk was 
judged to have decreased did not reduce between assessments.  
Conclusion: Violence risk changes very little over the course of treatment although there is 
some variation between groups. Most change cannot be demonstrated to be reliable or 
clinically significant. Important clinical management decisions should not depend solely on 
evidence from changes in HCR-20 risk assessment.  
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1. Introduction 
1
Structured professional judgment is the gold standard approach to violence risk 
assessment (1) and bridges the gap between unstructured clinical opinion and the purely 
actuarial. Whilst historical factors should form the basis of all risk assessments (2), the 
variable or dynamic risk factors that both precede violence and are potentially modifiable (3) 
are the most promising targets for interventions aimed at reducing future violence (4) and 
have therefore become a popular aspect of risk assessment schemes. Version 2 of the 
Historical, Clinical, Risk Management-20 (HCR-20; 5) is the most commonly used structured 
professional judgment tool in secure psychiatric units in the United Kingdom (6). It 
comprises 10 historical factors that are thought to be relatively static insomuch as once they 
are judged to be present they will remain so in most circumstances unless new behaviour is 
exhibited or new information comes to light (7); and 10 dynamic factors, which are divided 
into a clinical scale containing items about current clinical presentation, and a risk 
management scale comprising items about adjustment to future risk-related circumstances; 
each item is scored as present (2), possibly present (1), or absent (0) resulting in a maximum 
score of 40. The majority of the research into the HCR-20 has examined its predictive 
validity; such studies have been summarised in an annotated bibliography maintained by the 
tools authors (8). Studies of its predictive ability specifically among psychiatric inpatients 
have been synthesised in a recent meta-analysis (9).  
The ultimate aim of risk assessment is to identify management strategies and 
interventions to reduce identified risk factors and ultimately reduce the incidence of violence 
(4). It is therefore surprising that few studies have examined the ability of the HCR-20 to 
detect change in risk factors despite recommendations that the HCR-20 be repeated every 6 to 
                                                          
1
 HCR-20, Historical, Clinical, Risk-management-20; OAS, Overt Aggression scale; CI, confidence interval; 
DSPD, dangerous and severe personality disorder; RCI, reliable change index; R&CSC, reliable and clinically 
significant change; DUNDRUM, dangerousness, understanding, recovery and urgency manual 
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12 months (5). Those studies that have examined change in scores over time have been 
conducted in high secure settings. Longer treatment times have been found to be associated 
with reduced scores on the clinical and risk-management scales (10, 11) and mean scores 
reduce between the first and second HCR-20 assessments (12). Morrissey and colleagues (13) 
also found statistically significant reductions in dynamic items each year. However, across 
studies, average changes were small with total clinical scores reducing by 0.19 to 0.32 points 
and risk-management scores reducing by 0.14 to 0.31 points per iteration (12, 13). 
Examination of change in individual items by Olsson et al. (12) revealed that all individual 
clinical items reduced significantly, with the exception of C4 (impulsivity). Of the risk 
management items, R1 (plans lack feasibility) and R4 (noncompliance with remediation 
attempts) also reduced significantly. Current evidence suggests that women's scores reduce 
more than men's over time. Olsson et al. (12) found that women's scores were 2.2 times more 
likely than men's to reduce by 30% or more between assessments, and Morrissey et  al. (13) 
found that scores for women with a range of diagnoses decreased by an additional 0.23 points 
per year on the clinical scale relative to patients in a male mental illness service. In contrast, 
risk-management scores for the male patients resident in the Dangerous and Severe 
Personality Disorder (DSPD) and intellectual disability services increased relative to the 
mental illness group (13). 
1.1. Contribution of the current study 
 Previous research has demonstrated that clinical and risk-management scores reduce 
over time; however, the majority of the research has been conducted in high secure 
psychiatric settings where individuals will likely have higher baseline scores on risk 
assessments. Further, actual changes in scores have been modest and may not represent 
reliable or clinically significant change. Therefore, the current study aims to extend previous 
findings by investigating changes in HCR-20 ratings over time among patients resident in 
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medium and low secure services and determining whether any observed reduction in scores 
are reliable (i.e. unlikely to be due to measurement error) and clinically significant (i.e. scores 
reduce from those representative of a dysfunctional population to those of a relatively normal 
population). Previous evidence suggests that there may be differences in rates of change 
between services, or demographically and clinically defined groups; specifically, that women 
show a greater reduction in scores compared with men. Therefore, the current study aimed to 
further investigate changes in dynamic risk among patients in secure psychiatric services by 
examining which sample characteristics affect rate of change in HCR-20 scores. We also 
aimed to examine differences in rates of change of individual HCR-20 items between groups 
as the items that are most amenable to change for a given group may be most usefully 
prioritised as treatment targets.  
2. Method 
2.1. Setting 
 St. Andrew’s is a charitable provider of inpatient secure mental health care in 
England. Gender-specific, medium and low secure accommodation is provided in specialist 
diagnostic or demographically defined care pathways (e.g. older adults, autistic spectrum 
disorder). 
2.2. Participants 
 To be considered eligible, patients had to be aged 18 years or over, resident in any 
service between September 2010 and March 2011, and have at least two HCR-20 assessments 
completed by their clinical team. HCR-20 assessments were excluded if they were missing 
data exceeding prorating guidelines in the HCR-20 manual (5).  
2.3. Design and procedure 
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 The study was approved by the clinical audit and service evaluation committee and 
employed a pseudo-prospective design; HCR-20 assessments were completed as part of 
routine clinical practice by registered psychologists or graduate psychology assistants under 
their supervision prior to ratification by the clinical team. Risk assessment data, 
corresponding to up to four HCR-20 assessments per patient, and demographic and clinical 
information were extracted from anonymised patient records. 
2.4. Measures 
2.4.1. HCR-20 
Risk assessment was completed with version 2 of the HCR-20 (5), as version 3 (14) 
was not implemented in the study setting at the time of data collection.  The HCR-20 
comprises 20 items; 10 historical scale items that are thought to be relatively static, five 
clinical items that reflect the individuals’ current functioning, and five risk-management 
items that account for professional opinions regarding the individuals’ ability to adjust to 
either the institution (In ratings), or community (Out ratings). For the purpose of this study 
the “In ratings” were used as we were concerned with change in scores during their time in 
hospital. Each item is scored on a 3-point scale as either absent (0 or No), possibly present (1 
or Possible), or definitely present (2 or Yes). The psychopathy item was omitted as the 
majority of patients had not been assessed with the PCL-R (15); this has been found to have 
minimal effect on the predictive efficacy of the HCR-20 (16) and the item has been removed 
from version 3 (14). 
2.4.2. Patient characteristics 
Information regarding the patients’ age, gender, admission and discharge dates, legal 
status, security level, self-reported ethnicity, and ICD-10 (17) psychiatric diagnoses were 
extracted from patient records. In the UK secure mental health care is provided at three 
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levels: high security provides for patients assessed as posing a 'grave and immediate danger 
to the public'; medium security is suitable for patients who pose a 'serious danger to the 
public' while low secure is for those who pose a 'significant risk to others or themselves' (18). 
Security levels differ in the amount of physical and procedural security that is implemented to 
maintain safety. Civil commitments provide for assessment and/or treatment of those deemed 
at risk to themselves or others, while forensic commitments provide for assessment and/or 
treatment for patients diverted from criminal justice services or transferred temporarily from 
prison; informal patients are those admitted voluntarily and therefore not detained under the 
Mental Health Act (1983, Amended 2007). There were a large number of patients with both 
schizophrenia and personality disorder and they were therefore treated as a distinct comorbid 
group in the analysis. 
2.4.3. Aggression data 
 Incidents of aggression in the three month period following the first HCR-20 
assessment was extracted from patient records and coded using the Overt Aggression Scale 
(OAS; 19) as part of a previous study (20). Rating was conducted by three trained researchers 
blind to the HCR-20 risk assessments at the point of coding; inter-rater reliability was in the 
excellent range (Cohen’s Kappa 0.81-1.00). For the purpose of the current paper, we were 
only interested in physical aggression against others. This was dichotomised as present/absent 
based on meeting or exceeding the criteria for a level 1 incident on the OAS (makes 
threatening gesture, swings at people, grabs at clothes). 
2.5. Data analysis 
 Descriptive statistics were conducted to examine the prevalence of sample 
characteristics, HCR-20 summary judgment ratings, mean HCR-20 total, historical, clinical, 
and risk-management scores, and the presence of physical aggression towards others. Linear 
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mixed models, using maximum likelihood estimation, were used to examine baseline scores 
and rates of change in HCR-20 total, historical, clinical, risk-management, and individual 
item scores across assessments. Differences in rates of change between demographic and 
clinically defined groups were also examined. In order to examine whether time between 
assessments affected rates of change linear mixed models were also used to identify 
differences between individuals whose time between assessments fell outside of two standard 
deviations from the mean and those whose did not.  Mixed effects models were used as they 
allow for consideration of change in variables over time, differences in mean scores between 
groups, and interactions between time and group (i.e., whether rates of change differ between 
groups). Further, mixed effects models  account for varying number of assessments per 
patient thus maximising sample size; in contrast, repeated measures ANOVA models require 
removal of an entire patients’ dataset (listwise deletion) if data is missing for any time point 
(21). Assessment iteration was entered as the repeated measures variable, and was coded such 
that estimated intercept values could be interpreted as baseline scores, corresponding to the 
first assessment. Fixed effects are used to model the variables of interest (13); therefore, 
gender (reference category = male), age (reference category = aged less than 40 years), 
ethnicity (reference category = Caucasian), diagnosis (reference category = schizophrenia), 
intellectual disability (reference category = no intellectual disability), substance abuse 
(reference category = no substance abuse), Mental Health Act status (reference category = 
civil), security level of ward (reference category = low secure), and presence or absence of 
physical aggression towards others in the three months following the first HCR-20 
assessment (reference category = absent) were entered as fixed variables. Further, fixed 
effects were estimated for the interaction between assessment iteration and each of the 
factors; the resulting estimates correspond to the change in number of points with each 
iteration, relative to the reference group. The repeated HCR-20 assessments were modelled 
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with a random effect, to account for heterogeneity among patients’ scores (22). Cohen’s d 
values were calculated to examine the effect size of changes in scores and differences in 
baseline scores between groups; 0.2, 0.5, and 0.8 are typically considered the thresholds for 
small, medium, and large effect sizes.  
Finally, the Reliable Change Index (RCI; 23) was calculated to determine the number 
of individuals whose scores have changed sufficiently to be confident that observed change is 
not due to measurement error. More specifically, reliable change is the extent to which the 
change measured for an individual is beyond that which could be due to the measurement 
variability of the instrument used. The measurement variability, or RCI, is determined by 
calculating the SE of the difference, with the following formula: 
1 2 1diffSE SD r   
SD1 is the standard deviation of the baseline scores on the measure and r is the reliability of 
the measure. Change in scores that exceed 1.96 times the SE lie outside 95% of the area 
under a normal distribution curve and is thus unlikely to occur more than 5% of the time by 
unreliability of the measure alone. Internal consistency, as indicated by Cronbach’s α derived 
from HCR-20 ratings in the current study, was used as the measure of reliability (historical 
scale = .521, clinical scale = .614, risk-management scale = .738. Clinically significant 
change, defined as a change in score from a dysfunctional population to a normal population 
(23), was also calculated. Given the lack of available HCR-20 scores in a normal population 
(8), scores were compared against HCR-20 assessments rated at the point of discharge from 
medium secure units in the UK (24). Therefore, our operational definition for a clinically 
significant change in this study was movement from scale scores above previously published 
data for patients deemed to no longer require inpatient care to scores equal to or below those 
cut-offs. Cut-off points were established for the HCR-20 total score (25.3), historical scale 
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(12.7), clinical scale (5.0), and risk-management scale (5.1) based on criteria C outlined by 
Evans, Margison, and Barkham (23); this approach is recommended when there is an overlap 
in distribution of scores between the two populations. The number of individuals whose 
summary judgement risk level changed was calculated as a second measure of change that 
may be considered clinically significant; the HCR-20 authors recommend (5) that these 
summary judgments are used in clinical practice when communicating risk, as opposed to the 
numerical ratings, since different items may have a differential weight depending on the case 
at hand. All statistics were conducted using PASW Statistics version 18 for Windows (25).  
3. Results 
3.1. Sample characteristics 
There were 523 patients who had at least two HCR-20 assessments; 43 were excluded 
due to excessive missing information from assessments leaving a final sample size of 480. 
The mean time between the first and fourth assessments was 530.3 days (SD=61.8). Two 
thirds of the sample were male (n=321; 66.9%) and one third female (n=159, 33.1%). Mean 
age at assessment was 38.4 years (SD=15.6); for the purpose of analysis age was categorised 
as below 40 years of age (n=281, 58.5%) and aged 40 years and above (n=199, 41.5%).There 
were 225 Caucasian patients (46.9%), 35 Black patients (72.9%), 20 Asian patients (41.7%), 
25 patient with a mixed ethnic background (5.2%), 2 patients from an “other ethnic 
background" (0.4%), and 173 patients (36.0%) with no recorded ethnicity. For the purpose of 
analysis, these were grouped into Caucasian (n=225, 46.9%), non-Caucasian (n=82, 17.1%), 
and unknown (n=173, 36.0%). The most common ICD-10 [16] psychiatric diagnoses were 
“Schizophrenia, schizotypal and delusional disorders” (F20-29; n=256, 53.3%), “Disorders of 
adult personality and behaviour” (F60-69; n=206, 42.9%),“Mental retardation” (F70-79; 
n=91, 19.0%), “Disorders of psychological development” (F80-89; n=72, 15.0%), and 
“Organic, including symptomatic, mental disorders” (F00-09; n=40, 8.3%). For the purpose 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
12 
 
of analysis, diagnoses of “Mental retardation” (intellectual disability) and “Mental and 
behavioural disorders due to psychoactive substance use” (substance abuse) were entered as a 
separate variable, coded as present or absent, to minimise the level of complex co-morbidity 
in the sample. Participants were categorised according to the remaining ICD-10 major 
categories based on diagnosis within a single ICD-10 category; however, there were a large 
number of patients with comorbid schizophrenia and personality disorder, and these were 
treated as a distinct group. There were also a large number of patients with multiple or 
uncommon diagnoses that could not be grouped in any meaningful way into sufficiently large 
groups for analysis. Therefore, the final diagnostic groups were schizophrenia (n=180, 
37.5%), personality disorder (n=93, 19.4%), schizophrenia & personality disorder (n=40, 
8.3%), developmental (n=29, 6.0%), organic (n=22, 4.6%), and other or multiple (n=116, 
24.2%). At the time of assessment, 336 (70.0%) patients were resident in low secure wards 
and 144 (30.0%) were resident in medium secure wards. There were 188 patients (39.2%) 
admitted under civil sections of the Mental Health Act (1983, amended 2007), 271 (56.5%) 
admitted under forensic sections, and 21 (4.4%) informal patients. In the three months 
following the first HCR-20 assessment, 197 (41.0%) had engaged in physical aggression 
against others. 
3.2. HCR-20 assessments 
There were 162 (33.8%) patients who had only two HCR-20 assessments completed, 
218 (45.4%) had three assessments, and 100 (20.8%) had four assessments. The mean time 
between assessments was 181.5 days (SD=48.3). Deviation from the mean time between the 
assessments was defined as i) none, if the time between all of the individuals’ assessments 
fell within two standard deviations of the mean, ii) less, if the time between any of the 
individuals’ assessments was shorter than the mean minus two standard deviations, and iii) 
more, if the period between any of the individuals’ assessments was longer than the mean 
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plus two standard deviations. Examination of change in scores over time using deviation from 
the mean as a factor found that this did not affect rates of change for clinical (F[477,2]=0.65, 
p=.521), risk-management (F[427,2]=1.87, p=.156), historical (F[356,2]=1.68, p=.187), or 
total scores (F[425,2]=1.74, p=.177); therefore, all individuals were retained for the 
subsequent analyses. 
Across all assessments conducted at each time point, HCR-20 total scores ranged 
from 7 to 38 (Mean = 27.22; SD = 5.61). Historical, clinical and risk-management scale 
scores all spanned the total possible range; the mean historical score was 13.50, clinical score 
mean was 6.45 (SD = 2.36), and the mean risk-management score was 6.75 (SD = 2.47). The 
HCR-20 total score and dynamic scale scores decreased across subsequent assessments; 
however, the historical scale did not show this reduction and actual changes were very small. 
At all time points, moderate risk was the most common level assigned by the summary 
judgment. The proportion of individuals rated as low risk increased over time, and the 
proportion rated as high risk decreased; the largest reduction in high risk ratings and increase 
in low risk ratings was between the third and fourth assessments (see Table 1). 
3.3. Baseline scores 
3.3.1. Historical 
Baseline scores were 2.26 points lower in individuals with a developmental diagnosis 
and 3.25 points lower in those with organic diagnoses relative to those with schizophrenia 
(p<.001; d=.37, and p<.001; d=.47). Scores were also 1.28 points lower in patients admitted 
informally, compared with those admitted under civil sections of the Mental Health Act 
(p=.040; d=.18) and 1.41 points lower in individuals aged 40 years or over compared with 
those aged under 40 years (p<.001; d=.49). In contrast, scores were 0.67 points higher in 
medium secure patients compared with low secure (p=.018; d=.21), 1.57 points higher in 
individuals with comorbid schizophrenia and personality disorder compared with patients 
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with a sole diagnosis of schizophrenia (p=.001; d=.29), and 1.45 points higher in individuals 
with a substance abuse diagnosis, compared with those without (p<.001; d=.37). 
3.3.2. Clinical 
Baseline scores were 1.74 points lower (p<.001; d=.50) in those with a personality 
disorder, 1.41 points lower (p=.001; d=.30) in those with a developmental diagnosis, and 0.73 
points lower (p=.004; d=.25) in those with other or multiple diagnoses compared with those 
with schizophrenia. Scores were also 0.89 points lower (p<.001; d=.40) in forensic patients 
and 2.00 points lower (p<.001; d=.37) in informal patients compared with civil patients. 
Conversely, scores were 0.77 points higher in patients resident in medium secure wards 
compared with low secure wards (p<.001; d=.31), 0.68 points higher in women compared 
with men (p=.002; d=.26), , and 1.02 points higher in those who had been physically 
aggressive compared with those who had not (p<.001; d=.43).  
3.3.3. Risk-management 
Baseline scores were 0.71 points higher in those resident in medium secure wards 
compared with those in low secure wards (p=.002; d=.27), 0.49 points higher in women 
compared with men (p=.048; d=.17), 0.48 points higher in those with an unrecorded ethnicity 
compared with Caucasians (p=.035; d=.18), 0.53 points higher in those aged 40 years or over 
compared with those aged less than 40 years (p=.013; d=.22), and 1.06 points higher in 
individuals that had been aggressive relative to those who had not (p<.001; d=.41).  
3.3.4. Total  
Scores were 1.64 points lower in people with a personality disorder, 3.64 points lower 
in people with a developmental diagnosis,  and 2.90 points lower in people with an organic 
diagnosis, compared with individuals with schizophrenia (p=.028; d=.19, p<.001; d=.31, and 
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p=.012; d=.22, respectively). Scores were also 4.23 points lower in individual who were 
admitted informally, compared with civil patients (p<.001; d=.32). Scores were 2.33 points 
higher in patients resident in medium secure wards compared with those in low secure wards 
(p<.001; d=.39), 1.44 points higher in women compared with men (p=.010; d=.23), 1.83 
points higher in individuals with a substance abuse diagnosis compared to those without 
(p=.006; d=.24), and 1.94 points higher in individuals who had been physically aggressive 
compared with those who had not (p<.001; d=.33).  
3.4. Change in scores over time 
 Mean changes in HCR-20 total scores, subscale scores, and individual item scores are 
presented in Table 2.   
3.4.1. Historical 
There was no significant reduction in historical scores across assessments (0.05 
points, p=.556; d=.07). Individuals admitted informally reduced by an additional 0.36 points 
compared with those admitted under civil sections of the Mental Health Act (p=.037; d=.17). 
In contrast, individuals with an organic diagnosis increased by 0.53 points per assessment 
compared with those with schizophrenia (p=.001; d=.28). 
3.4.2. Clinical  
Across all participants, clinical scores reduced by 0.42 points per assessment (p<.001; 
d=.36). Individuals resident in medium secure wards decreased by an additional 0.19 points 
per assessment relative to those in low secure wards (p=.040; d=.19). In contrast, those with 
an organic diagnosis increased by 0.57 points per assessment, relative to those with 
schizophrenia (p=.017; d=.19), and those with a substance abuse diagnosis increased by 0.25 
points relative to those without a substance abuse diagnosis (p=.030; d=.21); individuals who 
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had been aggressive towards others increased by 0.33 points compared with those who had 
not been aggressive (p<.001; d=.31).  
3.4.3. Risk-management 
Across participants, there was no significant reduction in risk-management scores 
over time (-0.06 points per assessment; p=.583; d=.06). Medium secure patients decreased by 
an additional 0.27 points compared with low secure patients (p=.003; d=.28) and informal 
admissions decreased by an additional 0.57 points relative to patients admitted under civil 
sections of the Mental Health Act (p=.015; d=.19). Scores increased by 0.64 points for 
individuals with an organic diagnosis compared with those with schizophrenia (p=.005; 
d=.23). 
3.4.4. Total 
HCR-20 total scores reduced by an average of 0.42 points per assessment (p=.048; 
d=.20). Scores decreased by an additional 0.48 points per assessment in patients resident on 
medium secure wards relative to those on low secure wards (p=.007; d=.26). In contrast, 
scores increased by 1.54 points in those with an organic diagnosis compared with individuals 
with schizophrenia (p=.001; d=.27) and by 0.45 points in those who had been physically 
aggressive relative to those who had not (p=.013; d=.24). 
3.4.5. Individual items 
None of the individual historical items decreased significantly over repeated 
assessments. However, H3 (relationship instability) ratings for those aged 40 years and over 
decreased by an additional 0.04 points per assessment relative to younger patients; p=.021; 
d=.26). Mean scores for individuals with a developmental diagnosis decreased by a further 
0.08 on item H5 (substance use problems; p=.017; d=.31) and 0.12 on H9 (personality 
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disorder; p=.005; d=.34) compared with those with a diagnosis of schizophrenia. Mean scores 
for individuals with an organic diagnosis increased by 0.17 on item H1 (previous violence; 
p<.001; d=.68), 0.26 on item H6 (major mental illness; p<.001; d=.43), and 0.17 on H10 
(prior supervision failure, p=.001; d=.41). Individuals admitted under forensic sections of the 
Mental Health Act decreased by an additional 0.05 points and informal admissions decreased 
by 0.12 points on item H8 (early maladjustment) relative to those admitted under civil 
sections of the Mental Health Act (p=.005; d=.32 and p=.017; d=.20, respectively). 
Individuals admitted informally decreased by 0.12 points on item H10 relative to those 
admitted under civil sections of the Mental Health Act (p=.020; d=.24).  
With the exception of C5 (unresponsive to treatment), all of the clinical items reduced 
significantly across repeated assessments. However, mean scores of the medium secure group 
decreased by an additional 0.08 points on item C5 compared with those resident on low 
secure wards (p=.021; d=.21). Mean scores of individuals who had been physically 
aggressive towards others increased by 0.06 on item C1 (lack of insight; p=.006; d=.25), 0.06 
on C3 (active symptoms of major mental illness; p=.047; d=.19), 0.07 for item C4 
(impulsivity; p=.023; d=.21), and 0.09 on C5 (unresponsive to treatment; p=.008; d=.24) 
compared to individuals who had not been physically aggressive. Scores also increased on C5 
for individuals admitted under forensic sections of the Mental Health Act relative to those 
admitted under civil sections (0.07 points; p=.028; d=.21), and for individuals with a 
substance abuse diagnosis compared with those without (0.09 points; p=.020; d=.23). Mean 
scores of individuals who held other or multiple diagnoses increased by 0.07 on item C2 
(negative attitudes; p=.044; d=.20) and 0.08 on item C3 (p=.037; d=.21) relative to 
individuals with schizophrenia. Finally, mean scores of individuals who had co-morbid 
schizophrenia and personality disorder diagnoses increased by 0.14 on item C3 compared 
with those with a sole diagnosis of schizophrenia (p=.006; d=.29). 
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 None of the risk-management items decreased significantly over time. However, 
scores for individuals resident in medium secure wards decreased by a further 0.08 on item 
R4 (p=.005; d=.27) and 0.06 points on item R5 (stress; p=.023; d=.21) per assessment 
relative to low secure patients. Scores for those with a diagnosis of intellectual disability 
decreased by 0.09 on item R1 (plans lack feasibility; p=.017; d=.24) and 0.06 points on R3 
(lack of personal support; p=.043; d=.22) per assessment compared with those without an 
intellectual disability; the intellectual disability group increased by 0.06 points on item R5 
relative to those without intellectual disability (p=.048; d=.18). Scores for people admitted 
informally decreased by an additional 0.14 points on item R3 and 0.16 points on item R4 
relative to those admitted under civil sections of the Mental Health Act (p=.047; d=.15, and 
p=.042; d=.16). The organic group increased by 0.25 points for item R1 (p=.003; d=.24) and 
0.15 points for R5 (p=.021; d=.18) compared with the schizophrenia group. For item R4, 
women increased by 0.10 points relative to men (p=.002 ; d=.28). 
3.4.6. Reliable and clinically significant change 
The numbers of individuals who showed reliable and clinically significant change are 
presented in Table 3. There were three individuals who showed reliable reduction in scores 
between the first and third assessment (one on the risk-management scale and two on the total 
score) who could not show clinically significant change, as defined in the current study, as 
their scores for the first assessment were already below the cut-off point. Rates of change 
increased across repeated assessments, such that proportions of individuals demonstrating 
reliable and clinically significant change were greater between the first and fourth 
assessments than between the first and second or first and third assessments. However, a 
maximum of 3% of individuals showed clinically significant reliable reductions in HCR-20 
total scores over the study period. Across all comparisons, there were a greater number of 
individuals who demonstrated reliable and clinically significant reduction in scores on the 
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clinical (maximum 6%) and risk-management scales (maximum 5%) compared with the 
historical scale (maximum 1%).  
 Across each repeated assessment, a greater number of individuals decreased in risk 
level, as recorded by the summary judgment, than increased. A maximum of 0.9% of 
individuals decreased by two risk levels and 10.1% decreased by one risk level. Of those 
individuals who had decreased in risk level by the fourth assessment, only one had also 
showed reliable and clinically significant change in HCR-20 scores (see Table 4).   
4. Discussion 
The current study was the first to examine differences in rates of change in HCR-20 
scores between demographically and clinically defined groups in a medium and low secure 
psychiatric setting. Across the sample as a whole, total clinical scale scores reduced 
significantly with repeated assessment, as did all individual clinical scale items with the 
exception of C5 (unresponsive to treatment). Neither of the other scales nor any other 
individual items reduced significantly. These results suggest that clinical functioning 
improves over the course of inpatient treatment, but that coping skills and the ability to adjust 
to the institutional setting do not. Further, they lend support for the clinical scale as a variable 
risk factor but cast some doubt regarding whether the risk-management scale meets the same 
criteria (3). The overall group findings also support the idea that the historical scale 
comprises relatively static risk factors (3); however, small but statistically significant 
differences in rates of change between groups suggest that these items may not be as static as 
previously thought.  
Effect sizes for changes in scores were small. This may seem surprising, or even 
disappointing, since ratings were made in routine practice by clinical professionals who were 
also responsible for formulating individualized treatment and management plans to reduce 
risk based on the same assessment.  However, they slightly exceeded change in clinical 
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scores documented by previous research conducted in high security settings (12, 25). Given 
that greater reductions in risk levels were observed between the third and fourth assessments, 
it is possible that greater change would have been observed over a longer study period. 
Assessments in the current study were conducted over an average of 17 months; therefore 
future studies may wish to examine change in scores over a minimum period of two years to 
investigate this possibility. Alternatively, it may be that the dynamic HCR-20 items are not 
easily modified, or that clinical teams are not accurately identifying when changes in risk 
factors occur. The fact that the number of individuals whose overall assessed risk level 
reduced exceeded the number of individuals who showed a modestly defined clinically 
reliable significant reduction in scores lends support for the former. Practitioners appear to be 
reducing their overall perceptions of risk in the absence of reduction in HCR-20 scores, 
suggesting that they are sensitive to change but are basing their decision, at least in part, on 
factors outside the HCR-20. Alternatively, clinicians may be incorrectly adjusting their risk 
levels in the absence of real change in risk, as opposed to the items being insensitive to 
change.    
Baseline scores were broadly consistent with expectations such that medium secure 
patients and patients who were aggressive following the first HCR-20 assessment had higher 
scores; this likely reflects a need for increased security and greater risk of aggressive 
behaviour as the number of risk factors held by an individual increases. Conversely, scores 
were lower for informal admissions. This is consistent with evidence that the HCR-20 is able 
to differentiate between individuals at high risk of aggression, and those that are less likely to 
engage in such behaviour (8, 9, 20). Scores were also higher in individuals with 
schizophrenia, those with co-morbid schizophrenia and personality disorder, and those with 
substance abuse disorders. This is perhaps unsurprising given that three of the historical items 
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on the HCR-20 correspond to major mental illness, personality disorder, and substance abuse 
(5).  
Items C1 (lack of insight), C2 (negative attitudes), C3 (active symptoms of major 
mental illness), and C4 (impulsivity) showed the greatest reduction over repeated 
assessments. It may be that these items are those that are most amenable to change. 
Alternatively, it may be that they are the items that are most actively being targeted by 
interventions given the clinical, as opposed to correctional setting. 
Scores for individuals who were aggressive following the first HCR-20 assessment 
increased on all clinical items across repeated assessments, with the exception of C2 
(negative attitudes). This is as expected and suggests that aggressive behaviour may have in 
part been due to an increase in symptoms and worsening clinical presentation, as evidenced 
by increased clinical scale scores. This study had a low threshold for the presence of physical 
aggression (level 1 on the OAS); therefore, it is possible that even larger increases in clinical 
scores may have been observed for individuals engaging in more serious aggression. 
Individuals with more complex diagnoses, such as comorbid personality disorder and 
schizophrenia, multiple diagnoses, and comorbid substance abuse also tended to increase in 
scores on clinical items over time.  
Those with an organic diagnosis had lower HCR-20 total and historical scale scores at 
baseline compared with those with a diagnosis of schizophrenia; however, the organic group 
showed an increase in total and subscale scores, relative to the schizophrenia group. These 
findings suggest that the perceived risk of individuals with an organic diagnosis actually 
increases over the course of treatment This is perhaps not surprising as 63.6% of the patients 
with an organic diagnosis had a progressive neurological condition such as dementia or 
Huntington’s disease. The greatest increase in scores for this group was observed for H6 
(major mental illness), and R1 (plans lack feasibility); they also increased significantly on 
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items H1 (previous violence), H10 (prior supervision failure), and R5 (stress), relative to the 
schizophrenia group. However, the predictive validity of the HCR-20 for aggression among 
individuals with organic disorders has been found to be inferior to results achieved in 
individuals with personality disorders and schizophrenia (20). This suggests that the HCR-20 
may not contain the most relevant risk factors for aggression among this population and, 
therefore, increases in scores may not necessarily result in increases in aggressive behaviour.  
In contrast with previous findings (12, 26), women did not show a greater reduction in 
scores over time than men; they actually increased in scores on item R4 (noncompliance with 
remediation attempts) and had higher baseline total and dynamic scale scores compared with 
men.  Reasons for these differences in findings are unclear. However, the majority of women 
(n=116; 73.0%) in the current sample had a personality disorder diagnosis (with or without 
other co-morbidities). Personality disorders are pervasive, persistent and stable (17) and 
individuals with such diagnoses may be less likely to show a reduction in risk factors over 
time.  Neither Morriseey et al. (13) or Olsson et al. (12) present the diagnoses of their female 
sample. However, they may be expected to have demonstrated greater rates of change if their 
samples contain fewer individuals with personality disorder than the current study.  
4.1. Limitations  
The psychopathy item was excluded due to the vast majority of patients not being 
assessed with the PCL-R due to the additional time and expertise required. Whilst this has 
been found to have a negligible effect on predictive efficacy of the HCR-20 (16), this was not 
the focus of the current study. However, psychopathy has traditionally been viewed as an 
untreatable condition (27). Although this may be due to lack of effective treatments rather 
than people with the disorder being fundamentally untreatable (28), it suggests that this item 
may be unlikely to show much change over time. The study was naturalistic and pseudo-
prospective and, as a result, HCR-20 ratings from routine clinical practice were used. It is 
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possible that different raters completed assessments over time and we were unable to 
ascertain inter-reliability ratings for different raters. It is also possible that raters may 
consciously or unconsciously rate patients at lower risk over time to reflect assumed 
treatment progress. Finally, it may be surprising that Risk Management items and total score 
did not change over time since these are intended to be dynamic factors and may be 
modifiable through intervention. We used 'In' (risk in the inpatient situation) rather than 'Out' 
(risk in the community) ratings and it is possible that this contributed to temporal stasis for 
these items since patients would continue to have high levels of support under this 
conjectured condition.   
4.2. Implications and future considerations 
The current study has extended previous findings about change in risk over time as 
measured with the HCR-20. Very few patients showed reliable clinical change over the study 
period. However, given the time period over which the current study was conducted, more 
longitudinal research is needed to see if change accelerates or is sustained following lengthy 
periods of treatment. Future research should also establish whether any change in scores is 
associated with a reduction in incidents. Summary judgements may have been slightly better 
indicators of reliable change than scores; however, where judgements fell scores did not 
which suggests that the HCR-20 scores are not sensitive to change and clinical raters are 
basing their overall assessment of risk on factors other than those contained in the HCR-20. 
Therefore, it would be inadvisable to make major changes to risk management, including 
changes in security level, based on changes in HCR-20 score; more focused assessments, 
such as the DUNDRUM toolkit (29), should be used for this purpose.  
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Table 1: Distribution of HCR-20 total, scale scores, and summary judgment ratings as a 
function of assessment  
 Mean Scores (SD) Summary judgment risk rating 
Assessment Total Historical Clinical Risk-
management 
Low Moderate High 
1 27.49 
(5.69) 
13.50 
(3.12) 
6.81 
(2.32) 
6.81 (2.49) 80 
(23.7%) 
157 
(46.4%) 
101 
(29.9%) 
2 27.33 
(5.56) 
13.49 
(3.11) 
6.72 
(2.29) 
6.81 (2.43) 91 
(25.9%) 
158 
(44.9%) 
103 
(29.3%) 
3 26.97 
(5.58) 
13.53 
(2.82) 
6.43 
(2.47) 
6.71 (2.53) 64 
(28.4%) 
108 
(48.0%) 
53 
(23.6%) 
4 26.24 
(5.52) 
13.49 
(2.95) 
6.23 
(2.40) 
6.22 (2.39) 20 
(40.0%) 
23 
(46.0%) 
7 
(14.0%) 
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Table 2: Mean change in scores per assessment 
  
Item Estimate Std. Error 95%CI p d 
H1 0.00 0.01 [-0.02, 0.02] .980 .00 
H2 0.03 0.02 [-0.01, 0.23] .114 .19 
H3 0.01 0.02 [-0.03, 0.05] .690 .05 
H4 -0.01 0.02 [-0.06, 0.03] .519 .07 
H5 0.02 0.02 [-0.02, 0.06] .313 .10 
H6 -0.01 0.02 [-0.06, 0.04] .608 .05 
H8 0.03 0.02 [-0.01, 0.08] .137 .18 
H9 -0.00 0.03 [-0.06, 0.05] .920 .01 
H10 -0.02 0.02 [-0.06, 0.02] .330 .16 
Historical total 0.05 0.08 [-0.11, 0.20] .556 .07 
C1 -0.08 0.03 [-0.13, -0.03] .004 .28 
C2 -0.10 0.04 [-0.17, -0.03] .008 .27 
C3 -0.10 0.04 [-0.17, -0.02] .015 .25 
C4 -0.10 0.04 [-0.16, -0.02] .011 .25 
C5 -0.06 0.04 [-0.14, 0.02] .125 .15 
Clinical total -0.42 0.11 [-0.64, -0.20] <.001 .36 
R1 -0.06 0.04 [-0.14, 0.02] .113 .16 
R2 0.03 0.03 [-0.03, 0.10] .289 .12 
R3 0.01 0.03 [-0.05, 0.07] .679 .05 
R4 -0.05 0.04 [-0.11, 0.02] .201 .13 
R5 -0.00 0.03 [-0.06, 0.06] .963 .00 
Risk-management 
total 
-0.06 0.11 [-0.27, 0.15] .583 .06 
HCR-20 total -0.42 0.21 [-0.84, -0.01] .048 .20 
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Table 3: Number of individuals showing reliable and clinically significant reductions in 
scores 
 Assessment 1-2 Assessment 1-3 Assessment 1-4 
 RC (%) R&CSC  RC (%) R&CSC RC (%) R&CSC 
Historical 2 (0.4%) 2 (0.4%) 1 (0.3%) 1 (0.3%) 1 (1.0%) 1 (1.0%) 
Clinical 3 (0.6%) 3 (0.6%) 6 (1.9%) 6 (1.9%) 6 (6.0%) 6 (6.0%) 
Risk-
management 
9 (1.9%) 8 (1.7%) 12 (3.8%) 10 (3.1%) 7 (7.0%) 5 (5.0%) 
Total 6 (1.3%) 5 (1.2%) 6 (1.9%) 4 (1.3%) 4 (4.0%) 3 (3.0%) 
RC, reliable change; R&CSC, reliable and clinically significant change 
 
 
Table 4: Number of individuals whose summary judgment risk level reduced 
 Assessment 1-2 Assessment 1-3 Assessment 1-4 
Decreased     
1 level 25 (5.2%) 32 (10.1%) 8 (8.0%) 
2 levels 1 (0.2%) 3 (0.9%) 0 (0.0%) 
Increased     
1 level 8 (1.7%) 9 (2.8%) 2 (2.0%) 
2 levels 2 (0.4%) 0 (0.0%) 0 (0.0%) 
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